Pathogenesis of salt sensitivity of blood pressure

Current Hypertension Reports

Volumn 8, Issue 2, 2006, Pages 166-170

  Weinberger, Myron H ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ENDOCANNABINOID; ENDOTHELIN 1; MINERALOCORTICOID; NITRIC OXIDE; PROSTANOID; SODIUM CHLORIDE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL PROTOCOL; EXTRACELLULAR SPACE; GENETIC HETEROGENEITY; HUMAN; HYPERTENSION; HYPOKALEMIC ALKALOSIS; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SALT INTAKE; SENSITIVITY ANALYSIS; SODIUM INTAKE; SODIUM METABOLISM; UNITED STATES;

ANIMALS; BLOOD PRESSURE; ENDOCANNABINOIDS; ENDOTHELINS; EPITHELIAL SODIUM CHANNEL; HUMANS; HYPERTENSION; NITRIC OXIDE; OXIDATIVE STRESS; RATS; SALTS; SODIUM; SODIUM CHANNELS;

EID: 33744484524     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0014-y     Document Type: Review

References (43)

1. Weinberger MH, Miller JZ, Luft FC, et al.: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986, II-127-II-134.
2. Weinberger MH, Fineberg NS: Sodium and volume sensitivity of blood pressure: age and pressure change over time. Hypertension 1991, 18:67-71.
3. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M: Salt sensitivity, pulse pressure and death in normal and hypertensive humans. Hypertension 2001, 37:429-432.
4. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996, 27:481-490.
5. Kawasaki T, Delea CS, Bartter FC, Smith H: The effects of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978, 64:193-198.
6. Weinberger MH, Stegner JE, Fineberg NS: A comparison of two tests for the assessment of blood pressure responses to sodium. Am J Hypertens 1993, 6:179-184.
7. Campese VM, Romoff MS, Levitan J, et al.: Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982, 21:371-378.
8. Woods JW, Liddle GW, Michelakis AM, Brill AB: Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Arch Intern Med 1969, 123:366-370.
9. Grim CE, Weinberger MH: Familial, dexamethasone-suppressible normokalemic hyperaldosteronism. Pediatrics 1980, 65:597-604.
10. Lifton RP, Dluhy RG, Powers M, et al.: A chimeric 11 beta-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262-265.
11. O'Shaughnessy KM, Karet FE: Salt handling and hypertension. J Clin Invest 2004, 113:1075-1081.
12. Liddle G, Bledsoe T, Coppage W: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone excretion. Trans Assoc Am Physicians 1963, 76:199-213.
13. Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle's syndrome: heritable human hypertension caused by mutation in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407-414.
14. Hansson JH, Nelson-Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995, 11:76-82.
15. Naray-Fejes-Toth A, Canessa C, Cleaveland ES, et al.: sgk is an aldosterone-induced kinase in the renal collecting duct. Effects of epithelial Na+ channels. J Biol Chem 1999, 274:16973-16978.
16. Chen SY, Bhargava A, Mastroberardino L, et al.: Epithelial sodium channel regulated by aldosterone-induced protein sgk. PNAS 1999, 96:2514-2519.
17. Cheek DB, Perry JW: A salt wasting syndrome in infancy. Arch Dis Child 1958, 33:252-256.
18. Chang SS, Grunder S, Hanukoglu A, et al.: Mutations in subunits of epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I. Nat Genet 1996, 12:248-253.
19. Bartter FC, Pronove P, Gill LR Jr, et al.: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 1962, 33:811-828.
20. Bettinelli A, Bianchetti MG, Girardin E, et al.: Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992, 120:38-43.
21. Simon DB, Karet FE, Hamdan JM, et al.: Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2l cotransporter NKCC2. Nat Genet 1996, 13:183-188.
22. Gitelman HJ, Graham JB, Welt LG: A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Amer Phys 1966, 79:221-235.
23. Simon DB, Nelson-Williams C, Bia MJ, et al.: Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996, 12:24-30.
24. Gordon RA, Geddes RA, Pawsey CG, O'Halloran MW: Hypertension and severe hyperkalemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 1970, 19:287-294.
25. Wilson FH, Disse-Nicodeme S, Choate KA, et al.: Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112.
26. Kahle KT, Wilson FH, Leng Q, et al.: WNK4 regulates the balance between renal NaCl reabosrption and K+ secretion. Nat Genet 2003, 35:372-376.
27. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E: WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 2005, 46:758-765.
28. Naray-Fejes-Toth A, Snyder PM, Fejes-Toth G: The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium-channel mediated Na+ transport. PNAS 2004, 101:17434-17439.
29. Schiffrin EL: Vascular endothelin in hypertension. Vascul Pharmacol 2005, 43:19-29.
30. Herrera M, Garvin JL: A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1. Am J Physiol Renal Physiol 2005, 288:F58-F64.
31. Wang Y, Chen AF, Wang DH: ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 2005, 289:H2005-H2011.
32. Ohkita M, Wang Y, Nguyen ND, et al.: Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats. Hypertension 2005, 45:940-946.
33. Lim W, Lim D, Park JB, et al.: Sodium chloride regulation of the alpha epithelial amiloride-sensitive sodium channel (alphaENaC) gene requires syntheses of new protein(s). J Steroid Biochem Mol Biol 2004, 88:305-310.
34. Aoi W, Niisato N, Miyazaki H, Marunaka Y: Flavonoid-induced reduction of ENaC expression in the kidney of Dahl salt-sensitive hypertensive rat. Biochem Biophys Res Commun 2004, 315:892-896.
35. Cao YN, Kuwasako K, Kato J, et al.: Beyond vasodilation: the antioxidant effect of adrenomedullin in Dahl salt-sensitive rat aorta. Biochem Biophys Res Commun 2005, 332:866-872.
36. Taylor NE, Cowley AW Jr: Effect of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 2005, 289:R1573-1579.
37. Kopkan L, Majid DS: Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension 2005, 46:1026-1031.
38. Hisaki R, Fujita H, Saito F, Kushiro T: Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 2005, 18:707-713.
39. Welch WJ, Mendonca M, Blau J, et al.: Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 2005, 68:179-187.
40. Xu H, Bian X, Watts SW, Hlavacova A: Activation of vascular BK channel by Tempol in DOCA-Salt hypertensive rats. Hypertension 2005, 46:1154-1162.
41. Sausbier M, Arntz C, Bucurenciu I, et al.: Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 2005, 112:60-68.
42. Wang Y, Kaminski NE, Wang DH: VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension 2005, 46:986-991.
43. Wang J, Roman RJ, Flack JR, et al.: Effects of high-salt diet on CYP450-4A omega-hydroxylase expression and active tone in mesenteric resistance arteries. Am J Physiol Heart Circ Physiol 2004, 288:H1557-H1565.